Avinger, Inc. (NASDAQ:AVGR) Short Interest Update

Avinger, Inc. (NASDAQ:AVGR) saw a significant growth in short interest in the month of January. As of January 15th, there was short interest totalling 234,700 shares, a growth of 301.9% from the December 31st total of 58,400 shares. Based on an average daily volume of 1,990,000 shares, the days-to-cover ratio is currently 0.1 days. Approximately 8.5% of the shares of the company are sold short.

Avinger Stock Down 3.8 %

Avinger stock opened at $0.55 on Wednesday. The stock’s 50 day moving average is $0.75 and its 200-day moving average is $0.97. Avinger has a 12 month low of $0.39 and a 12 month high of $5.45.

Avinger (NASDAQ:AVGR) last posted its earnings results on Thursday, November 7th. The medical device company reported ($1.82) earnings per share for the quarter, topping analysts’ consensus estimates of ($2.03) by $0.21. Avinger had a negative return on equity of 5,527.11% and a negative net margin of 261.06%. The company had revenue of $1.65 million during the quarter, compared to the consensus estimate of $1.60 million. During the same quarter last year, the firm earned ($2.92) earnings per share. Research analysts predict that Avinger will post -4.69 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, StockNews.com started coverage on shares of Avinger in a report on Wednesday. They set a “hold” rating for the company.

About Avinger

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.